Real-World Challenges of AI in Drug R&D Regulation
zakkohane · x · 2026-07-16
Zak Kohane recommended an episode of the NEJM AI podcast featuring an interview with the CEO of Weave Bio.
The discussion focuses on the practical obstacles in the drug development regulatory process and how AI can drive substantive change in these areas, rather than just停留在 surface-level document processing applications.
Related event: Podcast Explores AI's Role in Transforming Drug Regulation(3 posts)→
More from Research
- SUFLECA shows NOC-based correspondence can improve CAD-to-image alignment — ducha_aiki · 2026-07-21
- OpenAI-style autonomous researchers could become real scientific collaborators — Promptmethus · 2026-07-21
- Soft Clamp cuts tool-call overuse in multi-teacher distillation, from 13.7% to 9.0% — antgroup · 2026-07-21
- ShotPlan adds learnable planning tokens for cinematic multi-shot video generation — Tele-AI · 2026-07-21
- A silicon photonic reservoir chip compensates fiber distortion in real time at 28 Gbps — bravo_abad · 2026-07-21
- A developer maps out six design rules for CLIs that humans and AI agents can both use — yujiezha · 2026-07-21